Simple research view

AMGN · Amgen Inc.

$376.26 latest stored close

Detected setup Trend Only

Watch · Quality 74/100

Ask about AMGN

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$AMGN

Amgen Inc.

Amgen Inc. is a mega-cap Biotechnology company in the Health Technology sector with a market cap of $203B.

Strong Buy · 91 Health Technology Biotechnology stock Stage 2 · Advancing Base 1 Data 59m ago

$376.26 latest close

← Back Join to Watchlist $AMGN Share card

Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Review six verdicts Inspect chart

Earnings-risk mode

Pre-earnings setup

Tuesday, August 4, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

AMGN+0.06%

Sector proxy · XLV+0.51%

Broad market · SPY+0.02%

Same completed session window ending 2026-07-27. AMGN was -0.45 points vs XLV. +0.04 points vs SPY.

CatalystUnavailable Stock reactionPositive Sector reactionSupportive Opening surgeUnavailable Event riskEarnings-driven

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.

Price $376.26 Jul 27 close

52W High $391.29 -3.8%

52W Low $269.77

Wks Since High 20w

Base Depth -18.1%

Base B1

SMA 50 $351.02

SMA 200 $341.92

Avg Vol 2,669,921

RS Rank 49

RS vs High -10.0%

RS Slope +4.6% ▲

Grp Rank #36/64

ADR% 2.3%

ATR(14) $8.46 (2.2%)

Rel Vol (today) 1.09×

Vol Pace N/A

U/D Vol 0.69

A/D Days 15A / 12D

A/D Rating A

VDU Bars 0/10 d

Power Trend 9d

Earnings 7d

$269.77

$391.29 88%

AMGN Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for AMGN.

Create Free Account

Setup Quality B 4/7 signals

Score trend

✓ Stage 2 · Advancing ✓ Power Trend 9d ✗ RS New High ✓ Trend 7/8 ✗ No Pattern ✓ Gatekeeper Base #1 (A)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$AMGN · $376.26 · as of 2026-07-27 · multi-factor read

/ 100

Strong Buy

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend

Weekly ▲ Uptrend

Monthly ▲ Recovering / early uptrend

Moving Averages

50-day$351.02 ↑

100-day$350.33 ↑

200-day$341.92 ↑

Bullish (50 > 200)

RSI (14)

Reading64.3 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish

Histogram+0.531

Bullish — MACD above its signal line and above zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width95% · 6.3%

Squeeze — volatility compressing

Near the upper band — buyers in control. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.69 · Neutral

Rel volume1.09×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $380.14swing level

R · $385.12swing level

R · $391.2952-week high

Price · $376.26now

S · $361.39swing level

S · $353.95swing level

S · $344.95swing level

Fibonacci · Downtrend swing

23.6%$337.22

38.2%$347.55

50.0%$355.90

61.8%$364.26

78.6% ◄ price here$376.15

Retracement resistance zones measured from the recent swing high down to the low.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for AMGN — plus the full 495-symbol scanner and Ask-the-Legends chat.

🔒 Start your 7-day free trial →

Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish

Want this read in a legend's voice? 💬 Ask a Legend about AMGN

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Watch

Minervini D

Trend-template read: 6/11 pass; wait for the soft misses to improve.

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $376.26, MA150 $350.23, MA200 $341.92

1.2 150-day MA > 200-day MAMA150 $350.23 vs MA200 $341.92

Failing evidence

1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 48

2. Quarterly EPS growth ≥ 25%From SEPA scan

6/11 checks

Method → Playbook → Ask →

O'Neil

Avoid

O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence

N: Near 52-week high or RS line new high3.8% below high | RS line new high: False

S: Base tightness (ATR% ≤ 4.5%)ATR% 2.25%

Failing evidence

L: RS rank ≥ 80 (IBD leadership)RS rank 48

C: Quarterly EPS acceleration ≥ 25%Data unavailable

2/8 checks

Method → Playbook → Ask →

Weinstein

Watch

Weinstein C

Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $376.26 vs MA200 $341.92

Failing evidence

Volume expansion above averageVolume ratio 1.09x

Relative strength ≥ 60RS 48

4/7 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$376.26

Distance from 52-week high3.8% below high

Failing evidence

Relative strengthRS 48

Volume vs average1.09x

3/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$376.26

Distance from 52-week high3.8% below high

Failing evidence

Relative strengthRS 48

Volume vs average1.09x

3/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$376.26

Distance from 52-week high3.8% below high

Failing evidence

Relative strengthRS 48

Volume vs average1.09x

3/6 checks

Method → Playbook → Ask →

Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

🕯 Latest candle: Doji — Open and close nearly equal — indecision. After a strong move it can signal a pause or pending reversal; wait for confirmation.

Unlock Follow-Through Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +1 A

Minervini · Grade Card

Fundamentals & leadership quality — Minervini SEPA criteria · 2/7 met

C 2/7 SEPA

Separate score from the 8-point Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ —

✗ Revenue growth ≥20% YoY +10%

✗ Gross margin ≥30% —

✗ ROE ≥17% —

✗ RS rating ≥80 (leadership) 48

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -3.8%

Method Playbook

📋 Trade it like Minervini EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

Minervini D · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.

Pivot

Pro level

Published-method rule: Use the tight base's structural pivot; the setup must retain Trend Template leadership into the trigger.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Require a decisive move through the pivot with volume confirmation, and do not initiate more than 5% above it.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Start at the tighter structural invalidation; the initial loss limit must not exceed roughly 7–8% from entry.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: Hold the initial stop until the trade proves itself; near +1R move to breakeven, then trail a higher low or rising 10/21-day average once well extended.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit when the structural stop or a meaningful higher-low/short-term trend violation fires; never widen the stop.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Forming Patterns (predictive — not confirmed)

Cup & Handle bullish early

60% built

Cup base building — 79% of the 18%-deep cup recovered. Watch for the right side to reach ~391.29, then a handle.

Pivot Watch 3.84% away

Tightness / volume Expanding · No VDU

Recent-pace band 3–10 sessions

Confirms above 391.29

Invalidates at 355.90

Rim 391.29

Cup Low 320.52

Pivot 391.29

Mid Cup 355.90

Cup depth 18%, recovery 79%, handle=not yet

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

Trend Only

73.6 score

RS Score 48

Trend 7/8 ✓

Why This Setup?

Trend Only

Gatekeeper 7/8 | Strong trend (7/8) | Power Trend | Stage 2

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

1/7 universals met

In a confirmed uptrend Stage 2 · Trend 7/8
Risk is defined No stop — undefined risk
Asymmetric reward No target set
Not chasing (in range) Pivot distance unknown
Volume confirms 1.1× average — light
Clear of earnings in 7 days — event risk
A relative-strength leader RS 49 — laggard

Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $376.26 vs SMA150 $350.23 / SMA200 $341.92

SMA 150 above SMA 200 SMA150 $350.23 vs SMA200 $341.92

SMA 200 trending up Slope +8.31 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $351.02

Price above SMA 50 $376.26 vs SMA50 $351.02

30%+ above 52W low +39.5% from $269.77

Within 25% of 52W high -3.8% from $391.29

RS score above 70 RS 48

Fundamentals

52W Range

88%

Mkt Cap SEC

203.1B

Rev YoY

+10%

EPS TTM

$14.23

P/E TTM

26.4x

Float

540M

Insider

No Buy

Company

Legend AI snapshot

Amgen Inc.

AMGN · NASDAQ · Health Technology · Biotechnology

$376.26latest close $203.1Bmarket cap 49RS rank 74setup score

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

8/8

W. RS

W. Support

$320.52

W. Resist

$391.29

Weekly Structure

Trend Neutral

Tight Weeks 0

Confirmation Neutral

Scan History

20× streak

Jul 28

Trend Only ✓ Gate

Jul 28

Trend Only ✓ Gate

Jul 27

Trend Only ✓ Gate

71 0.0%

Jul 24

Trend Only ✓ Gate

68 +0.1%

Jul 24

Trend Only ✓ Gate

68 +0.1%

Jul 24

Trend Only ✓ Gate

68 +0.1%

Get the full picture on AMGN

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial